Print Page

Letters to Healthcare Providers
 
Measures to minimise risk of suicidal thoughts with finasteride and dutasteride medicines (Letter to Healthcare Professionals)
 
 
 
Attachment:
  1. Measures to minimise risk of suicidal thoughts with finasteride and dutasteride medicines  
Related Information:
Canada: Summary Safety Review: Finasteride and Dutasteride: Assessing the potent... Posted 2026-07-31
Canada: Summary Safety Review - Finasteride and Dutasteride - Assessing the Pote... Posted 2026-06-26
The United Kingdom: Finasteride and Dutasteride – updated safety warnings for ps... Posted 2026-05-12
European Union: Measures to minimise risk of suicidal thoughts with finasteride ... Posted 2025-05-09
European Union: EMA has started a review of medicinal products containing finast... Posted 2024-10-05
The United Kingdom: Finasteride reminder of the risk psychiatric side effects an... Posted 2024-04-30
Canada: Summary Safety Review: Finasteride: Assessing the potential risks of sui... Posted 2023-01-20
Finasteride: Assessing the potential risks of suicide, suicidal thoughts (suicid... Posted 2023-01-20
Singapore: Finasteride and potential risk of suicidal ideation Posted 2022-08-31
Canada: Summary Safety Review - Proscar and Propecia (finasteride) - Assessing t... Posted 2019-02-27
The United Kingdom: Finasteride: rare reports of depression and suicidal thought... Posted 2017-05-25
Finasteride: rare reports of depression and suicidal thoughts (Letter to Healthc... Posted 2017-05-25
 
back